Adherencia a la medicación antipsicótica en pacientes indígenas con esquizofrenia

Alejandra Caqueo-Urízar, M. Alfonso Urzúa, Claudia Miranda-Castillo, Matías Irarrázaval

Research output: Contribution to journalArticle

Abstract

Introduction Non-adherence to antipsychotic medication remains a complex problem in the treatment of schizophrenia patients, especially in indigenous population. Objective The aim of the study was to assess the differences in drug adherence, measured by the attitude towards the antipsychotics among Aymara and Non-Aymara patients with schizophrenia. Method The sample consisted of patients receiving treatment in the Mental Health Public Services in Bolivia (32.8%), Peru (33.6%) and Chile (33.6%). We used the Drug Attitude Inventory (DAI-10); the Barnes Akathisia Scale (BAS), as a measure of side effects, and the Positive and Negative Syndrome Scale (PANSS) to assess the severity of the disorder. Results The findings showed that Aymara patients present less adherence than Non-Aymara people; however, these differences were not significant (t = 1.29; p = 0.19). The severity of the disorder, as well as the age, showed a significant association with adherence, revealing that younger patients and with greater symptoms presented a more negative attitude toward the drugs. Discussion and conclusion The lack of significant differences between the groups responds to three possible reasons: 1. This sample of indigenous patients is integrated on Mental Health Services that offer a clear biomedical approach where drug therapy is the primary treatment. 2. It is possible that these indigenous patients are changing their conception of mental disorder, and 3. A significant number of families have migrated to urban areas. These migratory dynamics have promoted the loss of traditions and customs of the ethnic group, which gradually adopts new and intercultural lifestyles. Professionals should be warned about applying stereotypes regarding the relationship between ethnicity and antipsychotics.

Original languageSpanish
Pages (from-to)303-310
Number of pages8
JournalSalud Mental
Volume39
Issue number6
DOIs
Publication statusPublished - 2016

ASJC Scopus subject areas

  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

Caqueo-Urízar, Alejandra ; Alfonso Urzúa, M. ; Miranda-Castillo, Claudia ; Irarrázaval, Matías. / Adherencia a la medicación antipsicótica en pacientes indígenas con esquizofrenia. In: Salud Mental. 2016 ; Vol. 39, No. 6. pp. 303-310.
@article{588be0ea31604f7fae6197c40f263b60,
title = "Adherencia a la medicaci{\'o}n antipsic{\'o}tica en pacientes ind{\'i}genas con esquizofrenia",
abstract = "Introduction Non-adherence to antipsychotic medication remains a complex problem in the treatment of schizophrenia patients, especially in indigenous population. Objective The aim of the study was to assess the differences in drug adherence, measured by the attitude towards the antipsychotics among Aymara and Non-Aymara patients with schizophrenia. Method The sample consisted of patients receiving treatment in the Mental Health Public Services in Bolivia (32.8{\%}), Peru (33.6{\%}) and Chile (33.6{\%}). We used the Drug Attitude Inventory (DAI-10); the Barnes Akathisia Scale (BAS), as a measure of side effects, and the Positive and Negative Syndrome Scale (PANSS) to assess the severity of the disorder. Results The findings showed that Aymara patients present less adherence than Non-Aymara people; however, these differences were not significant (t = 1.29; p = 0.19). The severity of the disorder, as well as the age, showed a significant association with adherence, revealing that younger patients and with greater symptoms presented a more negative attitude toward the drugs. Discussion and conclusion The lack of significant differences between the groups responds to three possible reasons: 1. This sample of indigenous patients is integrated on Mental Health Services that offer a clear biomedical approach where drug therapy is the primary treatment. 2. It is possible that these indigenous patients are changing their conception of mental disorder, and 3. A significant number of families have migrated to urban areas. These migratory dynamics have promoted the loss of traditions and customs of the ethnic group, which gradually adopts new and intercultural lifestyles. Professionals should be warned about applying stereotypes regarding the relationship between ethnicity and antipsychotics.",
keywords = "Adherence, Indigenous, Medication, Schizophrenia",
author = "Alejandra Caqueo-Ur{\'i}zar and {Alfonso Urz{\'u}a}, M. and Claudia Miranda-Castillo and Mat{\'i}as Irarr{\'a}zaval",
year = "2016",
doi = "10.17711/SM.0185-3325.2016.035",
language = "Spanish",
volume = "39",
pages = "303--310",
journal = "Salud Mental",
issn = "0185-3325",
publisher = "Instituto Mexicano de Psiquiatria",
number = "6",

}

Adherencia a la medicación antipsicótica en pacientes indígenas con esquizofrenia. / Caqueo-Urízar, Alejandra; Alfonso Urzúa, M.; Miranda-Castillo, Claudia; Irarrázaval, Matías.

In: Salud Mental, Vol. 39, No. 6, 2016, p. 303-310.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Adherencia a la medicación antipsicótica en pacientes indígenas con esquizofrenia

AU - Caqueo-Urízar, Alejandra

AU - Alfonso Urzúa, M.

AU - Miranda-Castillo, Claudia

AU - Irarrázaval, Matías

PY - 2016

Y1 - 2016

N2 - Introduction Non-adherence to antipsychotic medication remains a complex problem in the treatment of schizophrenia patients, especially in indigenous population. Objective The aim of the study was to assess the differences in drug adherence, measured by the attitude towards the antipsychotics among Aymara and Non-Aymara patients with schizophrenia. Method The sample consisted of patients receiving treatment in the Mental Health Public Services in Bolivia (32.8%), Peru (33.6%) and Chile (33.6%). We used the Drug Attitude Inventory (DAI-10); the Barnes Akathisia Scale (BAS), as a measure of side effects, and the Positive and Negative Syndrome Scale (PANSS) to assess the severity of the disorder. Results The findings showed that Aymara patients present less adherence than Non-Aymara people; however, these differences were not significant (t = 1.29; p = 0.19). The severity of the disorder, as well as the age, showed a significant association with adherence, revealing that younger patients and with greater symptoms presented a more negative attitude toward the drugs. Discussion and conclusion The lack of significant differences between the groups responds to three possible reasons: 1. This sample of indigenous patients is integrated on Mental Health Services that offer a clear biomedical approach where drug therapy is the primary treatment. 2. It is possible that these indigenous patients are changing their conception of mental disorder, and 3. A significant number of families have migrated to urban areas. These migratory dynamics have promoted the loss of traditions and customs of the ethnic group, which gradually adopts new and intercultural lifestyles. Professionals should be warned about applying stereotypes regarding the relationship between ethnicity and antipsychotics.

AB - Introduction Non-adherence to antipsychotic medication remains a complex problem in the treatment of schizophrenia patients, especially in indigenous population. Objective The aim of the study was to assess the differences in drug adherence, measured by the attitude towards the antipsychotics among Aymara and Non-Aymara patients with schizophrenia. Method The sample consisted of patients receiving treatment in the Mental Health Public Services in Bolivia (32.8%), Peru (33.6%) and Chile (33.6%). We used the Drug Attitude Inventory (DAI-10); the Barnes Akathisia Scale (BAS), as a measure of side effects, and the Positive and Negative Syndrome Scale (PANSS) to assess the severity of the disorder. Results The findings showed that Aymara patients present less adherence than Non-Aymara people; however, these differences were not significant (t = 1.29; p = 0.19). The severity of the disorder, as well as the age, showed a significant association with adherence, revealing that younger patients and with greater symptoms presented a more negative attitude toward the drugs. Discussion and conclusion The lack of significant differences between the groups responds to three possible reasons: 1. This sample of indigenous patients is integrated on Mental Health Services that offer a clear biomedical approach where drug therapy is the primary treatment. 2. It is possible that these indigenous patients are changing their conception of mental disorder, and 3. A significant number of families have migrated to urban areas. These migratory dynamics have promoted the loss of traditions and customs of the ethnic group, which gradually adopts new and intercultural lifestyles. Professionals should be warned about applying stereotypes regarding the relationship between ethnicity and antipsychotics.

KW - Adherence

KW - Indigenous

KW - Medication

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=85003874472&partnerID=8YFLogxK

U2 - 10.17711/SM.0185-3325.2016.035

DO - 10.17711/SM.0185-3325.2016.035

M3 - Article

VL - 39

SP - 303

EP - 310

JO - Salud Mental

JF - Salud Mental

SN - 0185-3325

IS - 6

ER -